Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matt Kalaycio

Showing results (61-70 of 155) with videos related to

Pageof 16
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|August 6, 2017
Long-Term Outcomes of Hairy Cell Leukemia Treated With Purine Analogs: A Comparison With the General PopulationYazan F Madanat, Lisa Rybicki, Tomas Radivoyevitch, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 27, 2019
Relapse Prevention with Tyrosine Kinase Inhibitors after Allogeneic Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblast Leukemia: A Systematic ReviewZabih Warraich, Pavan Tenneti, Theresa Thai, et al.
Hematology/Oncology and Stem Cell Therapy|October 20, 2019
Comparative effectiveness of busulfan/cyclophosphamide versus busulfan/fludarabine myeloablative conditioning for allogeneic hematopoietic cell transplantation in acute myeloid leukemia and myelodysplastic syndromeSagar S Patel, Lisa Rybicki, Brad Pohlman, et al.
Leukemia & Lymphoma|May 8, 2013
Successful use of very low dose subcutaneous decitabine to treat high-risk myelofibrosis with Sweet syndrome that was refractory to 5-azacitidineYang Liu, Ali Tabarroki, Steven Billings, et al.
Bone Marrow Transplantation|January 31, 2019
Psychosocial Assessment of Candidates for Transplant (PACT) as a tool for psychological and social evaluation of allogeneic hematopoietic cell transplantation recipientsSanghee Hong, Lisa Rybicki, Donna Corrigan, et al.
Leukemia & Lymphoma|September 4, 2008
Time to post-remission therapy is an independent prognostic factor in adults with acute lymphoblastic leukemiaAnjali S Advani, Tao Jin, Giridharan Ramsingh, et al.
BMC Cancer|July 29, 2010
Histone H4 acetylation by immunohistochemistry and prognosis in newly diagnosed adult acute lymphoblastic leukemia (ALL) patientsAnjali S Advani, Sarah E Gibson, Elizabeth Douglas, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 19, 2019
Early infectious complications after autologous hematopoietic cell transplantation for multiple myelomaShafia Rahman, Lisa Rybicki, Betty Ky Hamilton, et al.
Journal of Clinical Apheresis|August 6, 2019
Body mass index does not impact hematopoietic progenitor cell mobilization for autologous hematopoietic cell transplantationJack Khouri, Lisa Rybicki, Navneet S Majhail, et al.
Infection Control and Hospital Epidemiology|August 8, 2012
Development of a modified surveillance definition of central line-associated bloodstream infections for patients with hematologic malignanciesMegan J Digiorgio, Cynthia Fatica, Mary Oden, et al.
Pageof 16

Showing results (61-70 of 155) with videos related to

Sort By:
Pageof 16
Clinical Lymphoma, Myeloma & Leukemia|August 6, 2017
Long-Term Outcomes of Hairy Cell Leukemia Treated With Purine Analogs: A Comparison With the General PopulationYazan F Madanat, Lisa Rybicki, Tomas Radivoyevitch, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 27, 2019
Relapse Prevention with Tyrosine Kinase Inhibitors after Allogeneic Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblast Leukemia: A Systematic ReviewZabih Warraich, Pavan Tenneti, Theresa Thai, et al.
Hematology/Oncology and Stem Cell Therapy|October 20, 2019
Comparative effectiveness of busulfan/cyclophosphamide versus busulfan/fludarabine myeloablative conditioning for allogeneic hematopoietic cell transplantation in acute myeloid leukemia and myelodysplastic syndromeSagar S Patel, Lisa Rybicki, Brad Pohlman, et al.
Leukemia & Lymphoma|May 8, 2013
Successful use of very low dose subcutaneous decitabine to treat high-risk myelofibrosis with Sweet syndrome that was refractory to 5-azacitidineYang Liu, Ali Tabarroki, Steven Billings, et al.
Bone Marrow Transplantation|January 31, 2019
Psychosocial Assessment of Candidates for Transplant (PACT) as a tool for psychological and social evaluation of allogeneic hematopoietic cell transplantation recipientsSanghee Hong, Lisa Rybicki, Donna Corrigan, et al.
Leukemia & Lymphoma|September 4, 2008
Time to post-remission therapy is an independent prognostic factor in adults with acute lymphoblastic leukemiaAnjali S Advani, Tao Jin, Giridharan Ramsingh, et al.
BMC Cancer|July 29, 2010
Histone H4 acetylation by immunohistochemistry and prognosis in newly diagnosed adult acute lymphoblastic leukemia (ALL) patientsAnjali S Advani, Sarah E Gibson, Elizabeth Douglas, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 19, 2019
Early infectious complications after autologous hematopoietic cell transplantation for multiple myelomaShafia Rahman, Lisa Rybicki, Betty Ky Hamilton, et al.
Journal of Clinical Apheresis|August 6, 2019
Body mass index does not impact hematopoietic progenitor cell mobilization for autologous hematopoietic cell transplantationJack Khouri, Lisa Rybicki, Navneet S Majhail, et al.
Infection Control and Hospital Epidemiology|August 8, 2012
Development of a modified surveillance definition of central line-associated bloodstream infections for patients with hematologic malignanciesMegan J Digiorgio, Cynthia Fatica, Mary Oden, et al.
Pageof 16